NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

歐洲心血管介入設備市場-COVID-19的影響(2020-2026):MedSuite

Europe Interventional Cardiology Market Analysis - COVID19 - 2020-2026 - MedSuite

出版商 iData Research Inc. 商品編碼 975743
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
歐洲心血管介入設備市場-COVID-19的影響(2020-2026):MedSuite Europe Interventional Cardiology Market Analysis - COVID19 - 2020-2026 - MedSuite
出版日期: 2020年11月30日內容資訊: 英文
簡介

由於新型冠狀病毒感染(COVID19)的影響,歐洲心血管介入設備的市場規模在2020年估計為約9.28億歐元,比上年下降約27%。 2022年後,它將恢復到COVID-19之前的水平,預計到2026年將達到10億歐元。

該報告調查了歐洲心血管介入設備市場,分析了市場背景,目標疾病的患病率,COVID-19和其他市場影響因素,目標治療方法和手術數量的變化,它匯總了已售出的設備數量,市場規模,平均價格過渡/預測,按主要國家/地區劃分的設備類型/細分,市場份額,競爭狀況,主要公司的概況等。

數字列表

圖表列表

執行摘要

歐洲市場概述

競爭分析

市場趨勢

市場開發

目標治療

目標市場

修訂歷史記錄

調查方法

COVID-19的影響

  • 國家概況
  • 情景分析

疾病概述

  • 基本數據
  • 治療/診斷
  • 患者統計

產品評估

  • 產品組合
    • 冠狀動脈支架
    • 冠狀動脈球囊導管
    • 氣球膨脹裝置
    • 介入性冠狀動脈導管
    • 介入性冠狀動脈導絲
    • 冠狀動脈栓塞保護裝置
    • 冠狀動脈袋切除裝置
    • 冠狀血栓清除裝置
    • 冠狀動脈慢性完全阻塞裝置
    • 冠狀動脈導管鞘
    • 冠狀動脈閉合裝置
    • 診斷冠狀動脈導管和導絲
    • 冠狀動脈內超聲
    • 光學相干胃攝影
    • 截止閥
  • 法規問題/召回
    • Abbott
    • Boston Scientific
    • Cardinal Health
    • Medtronic
    • Merit Medical Systems
    • Terumo
  • 臨床試驗
    • 冠狀動脈支架
    • 冠狀動脈球囊導管
    • 氣球膨脹裝置
    • 介入性冠狀動脈導管
    • 冠狀動脈栓塞保護裝置
    • 冠狀動脈袋切除裝置
    • 冠狀動脈閉合裝置
    • 冠狀動脈內超聲
    • 冠狀動脈光學相干斷層掃瞄

歐洲介入式心臟設備市場:市場概述

  • 匯率
  • 市場概況
  • 趨勢分析:按部門
  • 增長動力/制約因素
  • 市場份額分析
  • 併購
  • 公司簡介
    • Abbott
    • Asahi Intecc
    • Boston Scientific
    • Cardinal Health
    • Cardiovascular Systems Inc.
    • Cook Medical
    • Medtronic
    • Merit Medical Systems
    • Penumbra
    • Philips
    • Teleflex
    • Terumo
  • SWOT分析
    • Abbott
    • Asahi Intecc
    • Boston Scientific
    • Cardinal Health
    • Cardiovascular Systems Inc.
    • Cook Medical
    • Medtronic
    • Merit Medical Systems
    • Penumbra
    • Philips
    • Teleflex
    • Terumo

國家概況

    • 人口
    • 人均GDP
    • 價格指數
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 貝內克斯
  • 斯堪的那維亞
  • 奧地利
  • 瑞士
  • 葡萄牙

操作數/程序

  • 血管造影
  • 血管成形術/PCI
  • SVG
  • FFR
  • IVUS
  • OCT
  • 導管法

冠狀動脈支架市場

  • 市場概況
  • 市場分析/預測
    • 普通冠狀動脈支架
    • 藥物洗脫支架
    • 裸金屬支架
  • 增長推進/抑制因素
  • 市場佔有率分析

冠狀動脈導管市場

  • 市場概況
  • 市場分析/預測
    • 普通冠狀動脈球囊導管
    • PTCA球囊導管
    • 藥物洗脫氣球
    • 特殊氣囊導管
  • 增長推進/抑制因素
  • 市場佔有率分析

介入性冠狀動脈導管市場

  • 市場分析/預測
  • 增長推進/抑制因素
  • 市場佔有率分析

介入性冠狀動脈引導市場

  • 市場分析/預測
  • 增長推進/抑制因素
  • 市場佔有率分析

冠狀動脈栓塞保護設備市場

  • 市場概況
  • 市場分析/預測
    • 大隱靜脈植入物
    • 保護機制
  • 增長動力/制約因素
  • 市場份額分析

冠狀動脈腫瘤切除器械市場

  • 市場概況
  • 市場分析/預測
    • 冠狀動脈斑塊全切除裝置
    • 機械袋切除裝置
    • 激光造口術設備
  • 增長推進/抑制因素
  • 市場佔有率分析

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_EUIC20_MS

Throughout this medical market research, the publisher analyzed 46 interventional cardiology companies across Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of EU Interventional Cardiology Device Market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an interventional cardiology procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered:

  • Procedure Volumes for the Interventional Cardiology Market in Europe - MedPro
  • Coronary Stent Market - MedCore
  • Coronary Balloon Catheter Market - MedCore
  • Interventional Coronary Catheter Market - MedCore
  • Interventional Coronary Guidewire Market - MedCore
  • Coronary Embolic Protection Device Market - MedCore
  • Coronary Atherectomy Device Market - MedCore
  • Introducer Sheath Market - MedCore
  • Coronary Vascular Closure Device (VCD) Market - MedCore
  • Diagnostic Coronary Catheter & Guidewire Market - MedCore
  • Coronary Intravascular Ultrasound (IVUS) Market - MedCore
  • Coronary Optical Coherency Tomography Market - MedCore

EU Interventional Cardiology Device Market Insights:

Due to COVID19, the European Interventional Cardiology market size declined by almost 27% from 2019, resulting in a valuation of approximately €928 million in 2020. The market size is expected to return to pre-COVID19 levels in 2022, and reach €1 billion in 2026.

Technologies such as computer tomography (CT), optical coherence tomography (OCT), and magnetic resonance imaging (MRI) are becoming more efficient at diagnosing cardiovascular diseases. These higher-resolution technologies are expected to be better at identifying cardiovascular disease during the first procedure, negating the need for a second procedure and limiting the total number of diagnostic procedures performed. Prices for these image-guided devices are much higher than traditional interventional devices, resulting in upwards pressure on market value.

Boston Scientific was the leading competitor in the European market for interventional cardiology devices in 2020. The company was the leader of several segments, including coronary stents, balloon catheters, embolic protection devices, and atherectomy devices.

Report Regional Coverage:

Throughout this research series, the publisher has covered several countries in great detail. The countries covered are:

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Benelux (Belgium, Netherlands, and Luxembourg)
  • Scandinavia (Denmark, Finland, Norway, and Sweden)
  • Switzerland
  • Austria
  • Portugal

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPE INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURES INCLUDED

MARKETS INCLUDED

VERSION HISTORY

RESEARCH METHODOLOGY

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

IMPACT OF COVID-19 ON THE EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKET

  • 2.1. INTRODUCTION
    • 2.1.1. Treatable Population and the COVID-19 Virus
    • 2.1.2. Market Specifics
  • 2.2. COUNTRY PROFILES
  • 2.3. ANALYSIS BY MARKET SEGMENT
    • 2.3.1. Best Case Scenario
    • 2.3.2. Base Case Scenario
    • 2.3.3. Worst Case Scenario

DISEASE OVERVIEW

  • 3.1. BASIC ANATOMY
  • 3.2. DISEASE TREATMENTS AND DIAGNOSTICS
    • 3.2.1. General Diagnostics
    • 3.2.2. Coronary Artery Disease (CAD)
    • 3.2.3. Myocardial Infarction (MI)
    • 3.2.4. Angina Pectoris
  • 3.3. PATIENT DEMOGRAPHICS
    • 3.3.1. General Statistics

PRODUCT ASSESSMENT

  • 4.1. INTRODUCTION
  • 4.2. PRODUCT PORTFOLIOS
    • 4.2.1. Coronary Stent Market
    • 4.2.2. Coronary Balloon Catheter Market
    • 4.2.3. Balloon-Inflation Device Market
    • 4.2.4. Interventional Coronary Catheter Market
    • 4.2.5. Interventional Coronary Guidewire Market
    • 4.2.6. Coronary Embolic Protection Device Market
      • 4.2.6.1. Saphenous Vein Grafts
      • 4.2.6.2. Protection Mechanism
      • 4.2.6.2.1. Filter Basket
      • 4.2.6.2.2. Distal Balloon Occlusion
    • 4.2.7. Coronary Atherectomy Device Market
      • 4.2.7.1. Laser Atherectomy
      • 4.2.7.2. Directional Coronary Atherectomy (DCA)
      • 4.2.7.3. Mechanical Atherectomy
    • 4.2.8. Coronary Thrombectomy Device Market
    • 4.2.9. Coronary Chronic Total Occlusion Device Market
    • 4.2.10. Coronary Introducer Sheath Market
      • 4.2.10.1. Femoral Approach
      • 4.2.10.2. Radial/Brachial Approach
    • 4.2.11. Coronary Vascular Closure Device Market
    • 4.2.12. Diagnostic Coronary Catheter & Guidewire
    • 4.2.13. Coronary Intravascular Ultrasound Market
    • 4.2.14. Optical Coherence Tomography Market
    • 4.2.15. Hemostasis Valve Market
  • 4.3. REGULATORY ISSUES AND RECALLS
    • 4.3.1. Abbott
      • 4.3.1.1. Coronary Stent
      • 4.3.1.2. Coronary Balloon Catheter
      • 4.3.1.3. Introducer Sheath
      • 4.3.1.4. Coronary Vascular Closure Device
    • 4.3.2. Boston Scientific
      • 4.3.2.1. Coronary Stent
      • 4.3.2.2. Coronary Balloon Catheter
      • 4.3.2.3. Balloon-Inflation Device
      • 4.3.2.4. Interventional Coronary Catheter
      • 4.3.2.5. Interventional Coronary Guidewire
      • 4.3.2.6. Coronary Thrombectomy
    • 4.3.3. Cardinal Health
      • 4.3.3.1. Coronary Stent
    • 4.3.4. Medtronic
      • 4.3.4.1. Coronary Stent
      • 4.3.4.2. Introducer Sheath
      • 4.3.4.3. Coronary Balloon Catheter
      • 4.3.4.4. Interventional Coronary Catheter
    • 4.3.5. Merit Medical Systems
      • 4.3.5.1. Introducer Sheath
    • 4.3.7. Terumo
      • 4.3.7.1. Interventional Coronary Catheter
      • 4.3.7.2. Introducer Sheath
      • 4.3.7.3. Coronary Vascular Closure Device
  • 4.4. CLINICAL TRIALS
    • 4.4.1. Coronary Stent
      • 4.4.1.1. Abbott
      • 4.4.1.2. Boston Scientific
      • 4.4.1.3. Medtronic
    • 4.4.2. Coronary Balloon Catheter
      • 4.4.2.1. Boston Scientific
      • 4.4.2.2. Medtronic
    • 4.4.3. Balloon Inflation Device
      • 4.4.3.1. Central Arkansas Veterans Healthcare System
      • 4.4.3.2. Guy's and St Thomas' NHS Foundation Trust
    • 4.4.4. Interventional Coronary Catheter
      • 4.4.4.1. Medtronic
      • 4.4.4.2. Philips
    • 4.4.5. Coronary Embolic Protection Device
      • 4.4.5.1. Icahan School of Medicine at Mount Sinai
      • 4.4.5.2. Javelin Medical
      • 4.4.5.3. Keystone Heart
      • 4.4.5.4. Microvention-Terumo, Inc
    • 4.4.6. Coronary Atherectomy Device
      • 4.4.6.1. Segeberger Kliniken GmbH
      • 4.4.6.2. Spectranetics Corporation
    • 4.4.7. Coronary Vascular Closure Device
      • 4.4.7.1. Cordis Corporation
      • 4.4.7.2. Medtronic
      • 4.4.7.3. Terumo Medical Corporation
    • 4.4.8. Coronary Intravascular Ultrasound
      • 4.4.8.1. Aarhhus University Hospital Skejby
      • 4.4.8.2. European Cardiovascular Research Institute
    • 4.4.9. Coronary Optical Coherence Tomography
      • 4.4.9.1. Columbia University

EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. CURRENCY EXCHANGE RATE
  • 5.3. MARKET OVERVIEW
  • 5.4. TREND ANALYSIS BY SEGMENT
  • 5.5. DRIVERS AND LIMITERS
    • 5.5.1. Market Drivers
    • 5.5.2. Market Limiters
  • 5.6. COMPETITIVE MARKET SHARE ANALYSIS
  • 5.7. MERGERS AND ACQUISITIONS
  • 5.8. COMPANY PROFILES
    • 5.8.1. Abbott
    • 5.8.2. Asahi Intecc
    • 5.8.3. Boston Scientific
    • 5.8.4. Cardinal Health
      • 5.8.4.1. Cordis (Cardinal Health)
    • 5.8.5. Cardiovascular Systems Inc.
    • 5.8.6. Cook Medical
    • 5.8.7. Medtronic
    • 5.8.8. Merit Medical Systems
    • 5.8.9. Penumbra
    • 5.8.10. Philips
    • 5.8.11. Teleflex
    • 5.8.12. Terumo
  • 5.9. SWOT ANALYSIS
    • 5.9.1. Abbott
    • 5.9.2. Asahi Intecc
    • 5.9.3. Boston Scientific
    • 5.9.4. Cardinal Health
    • 5.9.5. Cardiovascular Systems Inc.
    • 5.9.6. Cook Medical
    • 5.9.7. Medtronic
    • 5.9.8. Merit Medical Systems
    • 5.9.9. Penumbra
    • 5.9.10. Philips
    • 5.9.11. Teleflex
    • 5.9.12. Terumo

COUNTRY PROFILES

  • 6.1. INTRODUCTION
    • 6.1.1. Population
    • 6.1.2. GDP Per Capita
    • 6.1.3. Price Index
  • 6.2. GERMANY
  • 6.3. FRANCE
  • 6.4. UNITED KINGDOM
  • 6.5. ITALY
  • 6.6. SPAIN
  • 6.7. BENELUX
  • 6.8. SCANDINAVIA
  • 6.9. AUSTRIA
  • 6.10. SWITZERLAND
  • 6.11. PORTUGAL

PROCEDURE NUMBERS

  • 7.1. PROCEDURES
    • 7.1.1. Angiography Procedures
      • 7.1.1.1. Angiography Procedures by Approach
    • 7.1.2. Angioplasty/PCI Procedures
      • 7.1.2.1. Angioplasty/PCI Procedures by Approach
    • 7.1.3. SVG Procedures
    • 7.1.4. FFR Procedures
    • 7.1.5. IVUS Procedures
    • 7.1.6. OCT Procedures
    • 7.1.7. Catheterization Procedures

CORONARY STENT MARKET

  • 8.1. INTRODUCTION
  • 8.2. MARKET OVERVIEW
  • 8.3. MARKET ANALYSIS AND FORECAST
    • 8.3.1. Total Coronary Stent Market
    • 8.3.2. Drug-Eluting Stent Market
    • 8.3.3. Bare-Metal Stent Market
  • 8.4. DRIVERS AND LIMITERS
    • 8.4.1. Market Drivers
    • 8.4.2. Market Limiters
  • 8.5. COMPETITIVE MARKET SHARE ANALYSIS

CORONARY BALLOON CATHETER MARKET

  • 9.1. INTRODUCTION
  • 9.2. MARKET OVERVIEW
  • 9.3. MARKET ANALYSIS AND FORECAST
    • 9.3.1. Total Coronary Balloon Catheter Market
    • 9.3.2. PTCA Balloon Catheter Market
    • 9.3.3. Drug-Eluting Balloon Market
    • 9.3.4. Specialty Balloon Catheter Market
  • 9.4. DRIVERS AND LIMITERS
    • 9.4.1. Market Drivers
    • 9.4.2. Market Limiters
  • 9.5. COMPETITIVE MARKET SHARE ANALYSIS

INTERVENTIONAL CORONARY CATHETER MARKET

  • 10.1. INTRODUCTION
  • 10.2. MARKET ANALYSIS AND FORECAST
  • 10.3. DRIVERS AND LIMITERS
    • 10.3.1. Market Drivers
    • 10.3.2. Market Limiters
  • 10.4. COMPETITIVE MARKET SHARE ANALYSIS

INTERVENTIONAL CORONARY GUIDEWIRE MARKET

  • 11.1. INTRODUCTION
  • 11.2. MARKET ANALYSIS AND FORECAST
  • 11.3. DRIVERS AND LIMITERS
    • 11.3.1. Market Drivers
    • 11.3.2. Market Limiters
  • 11.4. COMPETITIVE MARKET SHARE ANALYSIS

CORONARY EMBOLIC PROTECTION DEVICE MARKET

  • 12.1. INTRODUCTION
    • 12.1.1. Saphenous Vein Grafts
    • 12.1.2. Protection Mechanism
  • 12.2. MARKET ANALYSIS AND FORECAST
  • 12.3. DRIVERS AND LIMITERS
    • 12.3.1. Market Drivers
    • 12.3.2. Market Limiters
  • 12.4. COMPETITIVE MARKET SHARE ANALYSIS

CORONARY ATHERECTOMY DEVICE MARKET

  • 13.1. INTRODUCTION
  • 13.2. MARKET OVERVIEW
  • 13.3. MARKET ANALYSIS AND FORECAST
    • 13.3.1. Total Coronary Atherectomy Device Market
    • 13.3.2. Mechanical Atherectomy Device Market
    • 13.3.3. Laser Atherectomy Device Market
  • 13.4. DRIVERS AND LIMITERS
    • 13.4.1. Market Drivers
    • 13.4.2. Market Limiters
  • 13.5. COMPETITIVE MARKET SHARE ANALYSIS